Mehran Risk Score for Contrast-Associated AKI (Post-PCI CIN)
Estimates risk of contrast-induced nephropathy after percutaneous coronary intervention from eight weighted clinical and renal factors, stratifying patients into low-to-very-high risk; this eGFR-tier version is separate from the updated 2021 Mehran CA-AKI model.